Canada Pension Plan Investment Board’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,400
Closed -$981K 1767
2026
Q1
$981K Buy
17,400
+11,100
+176% +$723K ﹤0.01% 1021
2025
Q4
$505K Buy
+6,300
New +$423K ﹤0.01% 1300
2024
Q4
Sell
-1,200
Closed -$96.5K 1447
2024
Q3
$96.5K Buy
1,200
+200
+20% +$16.2K ﹤0.01% 1172
2024
Q2
$82.7K Buy
+1,000
New +$88K ﹤0.01% 1215
2020
Q2
Sell
-518
Closed -$52K 1420
2020
Q1
$52K Sell
518
-49,482
-99% -$5.37M ﹤0.01% 1199
2019
Q4
$5.75M Buy
+50,000
New +$6.05M 0.01% 596
2018
Q2
Sell
-25,000
Closed -$1.83M 1261
2018
Q1
$1.83M Hold
25,000
﹤0.01% 990
2017
Q4
$1.45M Buy
+25,000
New +$1.32M ﹤0.01% 941

Other funds holding HAE

Canada Pension Plan Investment Board's HAE Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 17,400 shares — an estimated $981K sold.

Canada Pension Plan Investment Board first reported a position in HAE in Q4 2017 and held it in 8 quarters. The position peaked at $5.75M in Q4 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 17,400 Haemonetics shares in Q2 2026, an estimated $981K.
  • Canada Pension Plan Investment Board first reported a position in Haemonetics in Q4 2017 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Haemonetics position peaked at $5.75M in Q4 2019.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.